Nonglycosidic agonists of invariant NKT cells for use as vaccine adjuvants Journal Article

  

Authors:	Reddy, B. G.; Silk, J. D.; Salio, M.; Balamurugan, R.; Shepherd, D.; Ritter, G.; Cerundolo, V.; Schmidt, R. R.
Article Title:	Nonglycosidic agonists of invariant NKT cells for use as vaccine adjuvants
Keywords:	controlled study; unclassified drug; human cell; drug efficacy; nonhuman; antigen expression; animal cell; mouse; animals; mice; cancer immunotherapy; cell maturation; dendritic cell; interleukin 4; cell line; in vivo study; in vitro study; structure activity relation; enzyme linked immunosorbent assay; drug receptor binding; t lymphocyte receptor; lymphocyte activation; immune response; gamma interferon; cancer immunization; killer cells, natural; cytokine production; immunological adjuvant; immunomodulation; crystal structure; hydrogen bond; tumor model; receptor affinity; hybridoma; animal cell culture; adjuvants, immunologic; cytokine release; antigen presenting cell; vaccines; ceramide; adjuvants; glycolipid analogues synthesis; alpha galactosylceramide; alpha galactosylceramide derivative; arabinitolceramide; cd1d antigen; glycosphingolipid; threitolceramide derivative; natural killer t cell; spleen cell; glycosides
Journal Title:	ChemMedChem
Volume:	4
Issue:	2
ISSN:	1860-7179
Publisher:	Wiley Blackwell
Date Published:	2009-02-13
Start Page:	171
End Page:	175
Language:	English
DOI:	10.1002/cmdc.200800354
PUBMED:	19160440
PROVIDER:	scopus
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-60849102153&partnerID=40&md5=292253040cf33ae749309445d2c7eec7
Notes:	--- - "Cited By (since 1996): 3" - "Export Date: 30 November 2010" - "Source: Scopus"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/1312